Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11407740 Antibacterial compounds

Patent 11407740 was granted and assigned to Forge Therapeutics, Inc. on August, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Forge Therapeutics, Inc.

Current Assignee

Forge Therapeutics, Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114077400

Patent Inventor Names

Xiaoming Li0

Adele Faulkner0

Alastair Parkes0

Baskar Nammalwar0

Christian Perez0

David T. Puerta0

Holly Atton0

Ian Yule0

...

Date of Patent

August 9, 2022

Patent Application Number

172057500

Date Filed

March 18, 2021

Patent Citations

‌

US Patent 10875832 Substituted pyrimidines for treating bacterial infections

‌

US Patent 10130714 Enhanced anti-influenza agents conjugated with anti-inflammatory activity

‌

US Patent 10414735 Substituted hydroxypyrimidinones for treating bacterial infections

‌

US Patent 10611747 Pyrone based compounds for treating bacterial infections

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11407740 Antibacterial compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API